My watch list  

112 Current news from norway


You can refine your search further. Select from the filter options on the left to narrow down your results.

Nordic Nanovector: European Patent Granted for Betalutin or Humalutin in Combination With Anti-CD20 Antibodies for Treating NHL


Nordic Nanovector ASA announces that the European Patent Organisation (EPO) has granted the company's European Patent covering the use of Betalutin® or Humalutin® in combination with anti-CD20 antibodies for the treatment of non-Hodgkin's lymphoma (NHL). The same patent has also been issued in ...


CEPI awards US$ 34M contract to CureVac


The Coalition for Epidemic Preparedness Innovations (CEPI) and CureVac AG have announced a partnership agreement worth up to US$ 34 million for the ongoing development of The RNA Printer™ prototype—a transportable, down-scaled, automated messenger RNA (mRNA) printing facility. This platform will ...


Zelluna Immunotherapy appoints Miguel Forte as Chief Executive Officer

Appointment to drive Zelluna through next stage of international clinical-phase development


Zelluna Immunotherapy,the biotechnology company specializing in T-cell receptor (TCR) immunotherapies targeting a broad range of solid cancers with a high unmet medical need, today announces the appointment of Miguel Forte as chief executive officer (CEO). “Zelluna is developing a unique ...


image description
Asthma Medicine Halves Risk of Parkinson´s

These discoveries could be the start of a radically new treatment of Parkinson´s patients


Parkinson´s disease is a chronic disease with unknown causes. The disease destroys the brain cells that control body movements. Shivering, stiff arms and legs and poor coordination are typical symptoms of Parkinson´s. The symptoms may develop slowly, and it sometimes takes time to make a correct ...


New model developed to study inflammatory bowel disease in human biopsy samples


Inflammatory bowel disease (IBD) is a complex condition that requires a lifetime of care and increases a person's cancer risk. But its origins are still a mystery. Now, a team of researchers have created a new culture model of the human intestine where living tissue from a patient biopsy can be ...


Your blood can reveal your risk for heart disease


When you visit your general practitioner you can get your blood analyzed for cholesterol and triglycerides, to get an idea of your risk for cardiovascular disease. With additional information about BMI, smoking habits and blood pressure, this can be used to calculate your 10-year risk for ...


Preventing food waste better strategy than turning it into biogas


Turning your old banana peels and last night's leftovers into biogas sounds like a win-win situation for you and the environment: You don't have to feel guilty about having cooked too much pasta, and the use of biogas reduces CO2 emissions when it replaces fossil fuels. But a new study from the ...


BASF divests Omega-3 production plant


BASF has signed a definitive agreement to sell its manufacturing facility for natural fish oils, medium-concentrated omega-3s, and customized bottled fish oil in Brattvåg, Norway, to Marine Ingredients, a leading manufacturer of quality marine-based ingredients and customized products. Both ...


New Medicines from the Arctic Ocean

LDC and UiT The Arctic University of Norway Collaborate


The Lead Discovery Center GmbH (LDC), a renowned translational research organization, and UiT The Arctic University of Norway (UiT) have teamed up to discover new medicines from the marine arctic environment. The partners will focus on human diseases with high unmet medical need. UiT has gathered ...


Treating gastric cancer -- with Botox

Cutting the signals sent to cancer stem cells suppressed their growth


Researchers have found a novel approach to treating cancer - using Botox. A study presented in the 20 August edition of Science Translational Medicine shows that cancer growth could be suppressed by eliminating the signals sent by nerves that are linked to cancer stem cells. The approach thus ...


Page 1 From 12
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE